Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-44

No probs.

Hence my questioning earlier.. they appear in 20th now, but their original 7.1 mill holding is gone from the top 20 if I am correct..

Yes they were lead manager of the last CR from memory.

As per recent broker report from Argonaut:

https://www.botanixpharma.com/wp-content/uploads/2018-11-21-Botanix-BOT-Argonaut-Company-Update.pdf

"Important Disclosure Argonaut acted as Joint Lead Manager to the Placement that raised $15.0M in February 2018 and received fees commensurate with this service. Argonaut acted as Joint Lead Manager to the Placement that raised $8.0M in June 2018 and received fees commensurate with this service. Argonaut holds or controls 12.1M BOT Options exercisable at $0.03 on or before 30 June 2019."